- Home
- GNS vs ASRT Comparison
GNS vs ASRT Comparison
Compare GNS & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- ASRT
- Stock Information
- Founded
- GNS 2002
- ASRT 1995
- Country
- GNS Singapore
- ASRT United States
- Employees
- GNS N/A
- ASRT N/A
- Industry
- GNS Other Consumer Services
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- GNS Real Estate
- ASRT Health Care
- Exchange
- GNS Nasdaq
- ASRT Nasdaq
- Market Cap
- GNS 81.8M
- ASRT 79.1M
- IPO Year
- GNS 2022
- ASRT 1997
- Fundamental
- Price
- GNS $0.91
- ASRT $0.88
- Analyst Decision
- GNS
- ASRT Strong Buy
- Analyst Count
- GNS 0
- ASRT 1
- Target Price
- GNS N/A
- ASRT $3.00
- AVG Volume (30 Days)
- GNS 2.9M
- ASRT 323.8K
- Earning Date
- GNS 09-23-2025
- ASRT 11-10-2025
- Dividend Yield
- GNS N/A
- ASRT N/A
- EPS Growth
- GNS N/A
- ASRT N/A
- EPS
- GNS N/A
- ASRT N/A
- Revenue
- GNS $5,749,894.00
- ASRT $117,099,000.00
- Revenue This Year
- GNS $62.23
- ASRT N/A
- Revenue Next Year
- GNS $69.63
- ASRT $6.75
- P/E Ratio
- GNS N/A
- ASRT N/A
- Revenue Growth
- GNS N/A
- ASRT N/A
- 52 Week Low
- GNS $0.21
- ASRT $0.51
- 52 Week High
- GNS $1.92
- ASRT $1.16
- Technical
- Relative Strength Index (RSI)
- GNS 47.97
- ASRT 51.53
- Support Level
- GNS $0.91
- ASRT $0.87
- Resistance Level
- GNS $1.04
- ASRT $0.93
- Average True Range (ATR)
- GNS 0.08
- ASRT 0.04
- MACD
- GNS 0.00
- ASRT -0.01
- Stochastic Oscillator
- GNS 31.48
- ASRT 7.03
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.